Your browser doesn't support javascript.
loading
Prediabetes, Diabetes, and the Risk of All-Cause and Cause-Specific Mortality in a Japanese Working Population: Japan Epidemiology Collaboration on Occupational Health Study.
Islam, Zobida; Akter, Shamima; Inoue, Yosuke; Hu, Huan; Kuwahara, Keisuke; Nakagawa, Tohru; Honda, Toru; Yamamoto, Shuichiro; Okazaki, Hiroko; Miyamoto, Toshiaki; Ogasawara, Takayuki; Sasaki, Naoko; Uehara, Akihiko; Yamamoto, Makoto; Kochi, Takeshi; Eguchi, Masafumi; Shirasaka, Taiki; Shimizu, Makiko; Nagahama, Satsue; Hori, Ai; Imai, Teppei; Nishihara, Akiko; Tomita, Kentaro; Sone, Tomofumi; Konishi, Maki; Kabe, Isamu; Mizoue, Tetsuya; Dohi, Seitaro.
Afiliación
  • Islam Z; Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan zislam@hosp.ncgm.go.jp.
  • Akter S; Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
  • Inoue Y; Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hu H; Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kuwahara K; Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
  • Nakagawa T; Graduate School of Public Health, Teikyo University, Tokyo, Japan.
  • Honda T; Hitachi Health Care Center, Hitachi Ltd., Ibaraki, Japan.
  • Yamamoto S; Hitachi Health Care Center, Hitachi Ltd., Ibaraki, Japan.
  • Okazaki H; Hitachi Health Care Center, Hitachi Ltd., Ibaraki, Japan.
  • Miyamoto T; Mitsui Chemicals, Inc., Tokyo, Japan.
  • Ogasawara T; Nippon Steel Corporation, East Nippon Works, Chiba, Japan.
  • Sasaki N; Mitsubishi Fuso Truck and Bus Corporation, Kanagawa, Japan.
  • Uehara A; Mitsubishi Fuso Truck and Bus Corporation, Kanagawa, Japan.
  • Yamamoto M; Seijinkai Shizunai Hospital, Hokkaido, Japan.
  • Kochi T; Yamaha Corporation, Shizuoka, Japan.
  • Eguchi M; Furukawa Electric Co., Ltd., Tokyo, Japan.
  • Shirasaka T; Furukawa Electric Co., Ltd., Tokyo, Japan.
  • Shimizu M; Furukawa Electric Co., Ltd., Tokyo, Japan.
  • Nagahama S; Mizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan.
  • Hori A; All Japan Labour Welfare Foundation, Tokyo, Japan.
  • Imai T; Department of Global Public Health, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Nishihara A; OH Support, Kanagawa, Japan.
  • Tomita K; Azbil Corporation, Tokyo, Japan.
  • Sone T; Healthplant Co., Ltd., Tokyo, Japan.
  • Konishi M; National Institute of Public Health, Saitama, Japan.
  • Kabe I; Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mizoue T; Kubota Corporation, Tokyo, Japan.
  • Dohi S; Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Diabetes Care ; 44(3): 757-764, 2021 03.
Article en En | MEDLINE | ID: mdl-33441421
ABSTRACT

OBJECTIVE:

Prediabetes has been suggested to increase risk for death; however, the definitions of prediabetes that can predict death remain elusive. We prospectively investigated the association of multiple definitions of prediabetes with the risk of death from all causes, cardiovascular disease (CVD), and cancer in Japanese workers. RESEARCH DESIGN AND

METHODS:

The study included 62,785 workers who underwent a health checkup in 2010 or 2011 and were followed up for death from 2012 to March 2019. Prediabetes was defined according to fasting plasma glucose (FPG) or glycated hemoglobin (HbA1c) values or a combination of both using the American Diabetes Association (ADA) or World Health Organization (WHO)/International Expert Committee (IEC) criteria. The Cox proportional hazards regression model was used to investigate the associations.

RESULTS:

Over a 7-year follow-up, 229 deaths were documented. Compared with normoglycemia, prediabetes defined according to ADA criteria was associated with a higher risk of all-cause mortality (hazard ratio [HR] 1.53; 95% CI 1.12-2.09) and death due to cancer (HR 2.37; 95% CI 1.45-3.89) but not with death due to CVD. The results were materially unchanged when prediabetes was defined according to ADA FPG, ADA HbA1c, WHO FPG, or combined WHO/IEC criteria. Diabetes was associated with the risk of all-cause, CVD, and cancer deaths.

CONCLUSIONS:

In a cohort of Japanese workers, FPG- and HbA1c-defined prediabetes, according to ADA or WHO/IEC, were associated with a significantly increased risk of death from all causes and cancer but not CVD.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estado Prediabético / Salud Laboral / Diabetes Mellitus Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Determinantes_sociais_saude Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Care Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estado Prediabético / Salud Laboral / Diabetes Mellitus Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Determinantes_sociais_saude Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Care Año: 2021 Tipo del documento: Article País de afiliación: Japón